The beginnings date back to 1971 when a group of young entrepreneurs acquired a small laboratory in Madrid founded in 1954, called HIPRA (by the surnames of its former creators: Hidalgo and Prada), and moved to Amer (Girona).
HIPRA HQ in 1976
History
A lifetime of excellence, optimism and nonconformism
The year 1991, with a workforce of 100 people and a turnover of 10 million euros, was a crucial year in HIPRA's history. A new highly motivated management team redefines the company's expansion policy. Thus begins an important period of technical and commercial expansion.
Products from the 90's era
As of the year 2000, began the internationalization of HIPRA with the implementation of our own subsidiaries around the world. Currently HIPRA has commercial subsidiaries in 40 countries, 3 research centers and 6 production plants strategically located in Europe and America. Its extensive distribution network covers the 5 continents.
HIPRA Philippines, created in 2003, was one of the first HIPRA subsidiaries
In 2009 the strategic positioning was refined with the clear mission of being the world leader in prevention, with differential and innovative products and, therefore, it stopped investing in pharmacological products.
The logo and claim where HIPRA's commitment to prevention is reflected
In 2020, and in a context of the Covid-19 pandemic, a new challenge was faced using its extensive experience in innovative vaccines, the development of the vaccine against this new virus based on recombinant protein.
HIPRA expanded its facilities for human health
In 2021 the new Human Health division was created to develop new innovative products. The same year GoodGut was acquired, a biotechnological start-up dedicated to the research and development of diagnostic tests for digestive diseases.
GoodGut facilities
